Xeris Biopharma Holdings (XERS) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to 0.0.
- Xeris Biopharma Holdings' Equity Ratio rose 9736.32% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 9736.32%. This contributed to the annual value of 0.09 for FY2024, which is 33605.15% down from last year.
- According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Equity Ratio is 0.0, which was up 9736.32% from 0.06 recorded in Q2 2025.
- Xeris Biopharma Holdings' 5-year Equity Ratio high stood at 0.31 for Q4 2021, and its period low was 0.11 during Q1 2025.
- In the last 5 years, Xeris Biopharma Holdings' Equity Ratio had a median value of 0.0 in 2025 and averaged 0.05.
- Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 106879.57% in 2022, then plummeted by 84805.2% in 2024.
- Xeris Biopharma Holdings' Equity Ratio (Quarter) stood at 0.31 in 2021, then tumbled by 58.08% to 0.13 in 2022, then crashed by 116.03% to 0.02 in 2023, then plummeted by 336.05% to 0.09 in 2024, then soared by 97.46% to 0.0 in 2025.
- Its Equity Ratio stands at 0.0 for Q3 2025, versus 0.06 for Q2 2025 and 0.11 for Q1 2025.